MECOM
MECOM (MDS1 and EVI1 complex locus, also known as EVI1, MDS1, MDS1-EVI1, PRDM3 and KMT8E) is a zinc-finger transcriptional regulator and oncoprotein with histone methyltransferase activity. It is linked to haematopoiesis, apoptosis, development and cell differentiation and proliferation. Browse Assay Genie's current range of MECOM research reagents below, or read on for the biology behind the target.
MECOM displays histone methyltransferase activity and monomethylates lysine 9 of histone H3 (H3K9me1). It is thought to catalyse the monomethylation of free histone H3 in the cytoplasm. This histone is then transported to the nucleus and incorporated into nucleosomes, where SUV39H methyltransferases use it as a substrate for histone H3 lysine 9 trimethylation. MECOM is likely to be one of the primary histone methyltransferases, along with PRDM16, that direct cytoplasmic H3K9me1 methylation.
The MECOM gene encodes a transcriptional regulator and oncoprotein that may be involved in haematopoiesis, apoptosis, development, and cell differentiation and proliferation. The encoded protein can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8 and MAPK9. HGNC places it in the C2H2-type zinc finger, PR/SET domain and putative lysine methyltransferase gene groups. UniProt records the protein in the nucleus, nuclear speckles and cytoplasm. Several transcript variants encoding a few different isoforms have been described for the MECOM gene, and the mouse ortholog is Mecom.
The many symbols reflect the locus history. The previous names are myelodysplasia syndrome 1 (MDS1) and ecotropic viral integration site 1 (EVI1), and MDS1-EVI1 denotes the combined locus. The gene can undergo translocation with the AML1 gene, which results in overexpression of MECOM and the onset of leukaemia, making it a recurrent subject in leukaemia research.
Translocation of the gene with AML1 leads to MECOM overexpression and the onset of leukaemia, so the protein is studied as an oncoprotein.
MECOM may be involved in haematopoiesis, cell differentiation and proliferation, making it relevant to studies of blood cell development.
MECOM monomethylates histone H3 lysine 9, supplying substrate for SUV39H-mediated trimethylation and informing work on H3K9 methylation.
MECOM can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8 and MAPK9, offering routes into regulatory and signalling complexes.
MECOM is a transcriptional regulator and oncoprotein with histone methyltransferase activity. It monomethylates histone H3 lysine 9, probably on free cytoplasmic histone H3, which SUV39H enzymes later trimethylate in nucleosomes. It may also be involved in haematopoiesis, apoptosis, development, differentiation and proliferation.
The locus has been named from several directions: EVI1 (ecotropic viral integration site 1), MDS1 (myelodysplasia syndrome 1), the combined MDS1-EVI1, and PRDM3 and KMT8E from its PR/SET methyltransferase features. MECOM is the approved HGNC symbol. Several transcript variants encode a few different isoforms.
The MECOM gene can undergo translocation with the AML1 gene, which causes its overexpression and the onset of leukaemia. The mouse ortholog is Mecom. Check the datasheet of any product for its validated reactivity.
Histone methyltransferases, transcriptional co-regulators and signalling proteins that interact with MECOM or share its pathways.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q03112; product specifications from Assay Genie datasheets.